Open access
Sep 2026
Efficacy and Safety of Reduced-Dose Chemotherapy Plus Nivolumab in Elderly Advanced Gastric Cancer
Background/Objective: The standard first-line treatment for advanced or recurrent gastric cancer (AGC) includes chemotherapy combined with an immune checkpoint inhibitor or zolbetuximab, but delivering fluoropyrimidine-platinum chemotherapy at standard doses can be difficult in elderly patients. Method: We retrospectiv...
Toshihiko Matsumoto, S. Sugimoto, R. Omori et al.
· Gastroenterology Insights · 0 citations